GB Sciences, Inc.
GBLX
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -100.40K | -190.50K | -285.00K | -467.00K | -187.30K |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 10.70K |
| Total Other Non-Cash Items | -- | -- | -- | 0.00 | -85.00K |
| Change in Net Operating Assets | -23.90K | 82.80K | 263.00K | 214.60K | 56.20K |
| Cash from Operations | -124.30K | -107.70K | -22.00K | -252.50K | -205.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 85.00K |
| Cash from Investing | -- | -- | -- | 0.00 | 85.00K |
| Total Debt Issued | 125.00K | 110.00K | -- | 247.00K | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 10.00K | -- | 33.30K |
| Repurchase of Common Stock | -- | -- | -- | -17.80K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 17.80K | 0.00 |
| Cash from Financing | 125.00K | 110.00K | 10.00K | 247.00K | 33.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | 700.00 | 2.30K | -12.00K | -5.50K | -87.10K |